# Correction: Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up

**Authors:** Ryosuke Sato, Katsuyuki Hotta, Toshio Kubo, Shigeru Horiguchi, Hironari Kato, Kazuyuki Matsumoto, Toshiyuki Kozuki, Heiichiro Udono, Katsuyuki Kiura, Motoyuki Otsuka

PMC · DOI: 10.7759/cureus.c365 · Cureus · 2025-10-16

## Full-text entities

- **Diseases:** Pancreatic Cancer (MESH:D010190)
- **Chemicals:** Metformin (MESH:D008687), Nivolumab (MESH:D000077594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12531398/full.md

---
Source: https://tomesphere.com/paper/PMC12531398